Cardiovascular prevention: Current progress and the long road to travel;Prevención cardiovascular: avances y el largo camino por recorrer

Revista Espanola de Cardiologia

Volumn 63, Issue SUPPL. 2, 2010, Pages 49-54

  Marrugat, Jaume ^a   Sala, Joan ^a   Elosua, Roberto ^a   Ramos, Rafael ^a   Baena Díez, José Miguel ^a  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

Author keywords

Cardiovascular disease; Ischemic heart disease; Primary prevention

Indexed keywords

BIOLOGICAL MARKER;

ANKLE BRACHIAL INDEX; ARTERIAL WALL THICKNESS; ARTERY MEDIA; CARDIOVASCULAR RISK; GENETIC PREDISPOSITION; ISCHEMIC HEART DISEASE; PRIMARY MEDICAL CARE; REVIEW; RISK ASSESSMENT;

EID: 77953935063     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(10)70152-4     Document Type: Article

References (55)

1. 4th Joint Task Force European guidelines for CHD prevention Eur Heart J 28 2007 2375 2414
2. A. Maiques-Galán, C. Brotons-Cuixart, F. Villar-Alvárez, F. Lobos-Bejarano, J. Torcal-Laguna, and D. Orozco-Beltrán Recomendaciones preventivas cardiovasculares en PAPPS Acualización'09. Programa de actividades preventivas y de promoción de la salud. Sociedad Española de Medicina de Familia y Comunitaria 2009 SEMFYC Ediciones Barcelona p. 101
3. K. Bibbins-Domingo, G.M. Chertow, P.G. Coxson, A. Moran, J.M. Lightwood, and M.J. Pletcher Projected effect of dietary salt reductions on future cardiovascular disease N Engl J Med 362 2010 590 599
4. A. Zamora, E. Elosua, and J. Marrugat El tabaco como factor de riesgo cardiovascular en las poblaciones mediterráneas Clin Invest Arterioscl 16 2004 207 220
5. G. Rose Sick individuals and sick populations Int J Epidemiol 14 1985 32 38
6. G. Rose The strategy of preventive medicine 1992 Oxford University Press New York
7. J. Emberson, P. Whincup, R. Morris, M. Walker, and S. Ebrahim Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease Eur Heart J 25 2004 484 491
8. D.M. Lloyd-Jones, E.P. Leip, M.G. Larson, R.B. D'Agostino, A. Beiser, and P.W. Wilson Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age Circulation 113 2006 791 798
9. M. Grau, I. Subirana, R. Elosua, P. Solanas, R. Ramos, and R. Masiá Trends in cardiovascular risk factor prevalence (1995-2000-2005) in northeastern Spain Eur J Cardiovasc Prev Rehabil 14 2007 653 659
10. P.G. Steg, D.L. Bhatt, P.W. Wilson, R. D'Agostino, E.M. Ohman, and J. Röther One-year cardiovascular event rates in outpatients with atherothrombosis JAMA 297 2007 1197 1206
11. C. Suárez, J. Castillo, E. Esmatjes, J. Sala, M. Cairols, and C. Montoto [Cardiovascular complications at 1-year of follow-up in patients with atherothrombosis. On behalf of Spain's REACH Registry] Med Clin (Barc) 132 2009 537 544
12. M. Gil, H. Martí, R. Elosua, M. Grau, J. Sala, and R. Masiá Análisis de la tendencia en la letalidad, incidencia y mortalidad por infarto de miocardio en Girona entre 1990 y 1999 Rev Esp Cardiol 60 2007 349 356
13. E. Braunwald Epilogue: What do clinicians expect from imagers? J Am Coll Cardiol 47 2006 C101 C103
14. D.D. Heistad Unstable coronary-artery plaques N Engl J Med 349 2003 2285 2287
15. S. Lerakis, A. Synetos, K. Toutouzas, M. Vavuranakis, E. Tsiamis, and C. Stefanadis Imaging of the vulnerable plaque: Noninvasive and invasive techniques Am J Med Sci 336 2008 342 348
16. US Preventive Task Force Using non-traditional risk factors in coronary heart disease risk assessment: U.S. Preventive Services Task Force Recommendation Statement An Int Med 151 2009 474 482
17. M. Naghavi, E. Falk, H.S. Hecht, M.J. Jamieson, S. Kaul, D. Berman SHAPE Task Force From vulnerable plaque to vulnerable patient-Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report Am J Cardiol 98 2006 2H 15H
18. M. Naghavi, P. Libby, E. Falk, S.W. Casscells, S. Litovsky, and J. Rumberger From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I Circulation 108 2003 1664 1672 (Pubitemid 37243650)
19. M. Naghavi, P. Libby, E. Falk, S.W. Casscells, S. Litovsky, and J. Rumberger From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II Circulation 108 2003 1772 1778 (Pubitemid 37296082)
20. D.H. O'Leary, J.F. Polak, R.A. Kronmal, T.A. Manolio, G.L. Burke, and S.K. Wolfson Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group N Engl J Med 340 1999 14 22
21. P.M. Ridker, N. Rifai, L. Rose, J.E. Buring, and N.R. Cook Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events N Engl J Med 347 2002 1557 1565
22. M.G. Shlipak, L.F. Fried, M. Cushman, T.A. Manolio, D. Peterson, and C. Stehman-Breen Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors JAMA 293 2005 1737 1745
23. A. Simon, G. Chironi, and J. Levenson Comparative performance of subclinical atherosclerosis tests in predicting coronary heart disease in asymptomatic individuals Eur Heart J 28 2007 2967 2971
24. N. Eldrup, H. Sillesen, E. Prescott, and B.G. Nordestgaard Ankle brachial index, C-reactive protein, and central augmentation index to identify individuals with severe atherosclerosis Eur Heart J 27 2006 316 322
25. W. Koenig, H. Lowel, J. Baumert, and C. Meisinger C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany Circulation 109 2004 1349 1353
26. I.M. Van der Meer, M.P. De Maat, A.J. Kiliaan, D.A. Van der Kuip, A. Hofman, and J.C. Witteman The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study Arch Intern Med 163 2003 1323 1328
27. P.W. Wilson, B.H. Nam, M. Pencina, R.B. D'Agostino, E.J. Benjamin, and C.J. O'Donnell C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study Arch Intern Med 165 2005 2473 2478
28. J. Marrugat, I. Subirana, E. Comin, C. Cabezas, J. Vila, and R. Elosua Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA study J Epidemiol Community Health 61 2007 40 47
29. A. Cabrera de León, J.J. Alemán Sánchez, M.C. Rodríguez Pérez, J.C. Del Castillo-Rodríguez, S. Domínguez-Coello, and D. Almeida-González [Framingham function estimates the risk of cardio vascular mortality more effectively than SCORE function in the population of the Canary Islands (Spain)] Gac Sanit 23 2009 216 221
30. P. González-Diego, C. Moreno-Iribas, M.J. Guembe, J.J. Viñes, and J. Vila Adaptación de la función de riesgo coronario de Framingham-Wilson para la población de Navarra (RICORNA) Rev Esp Cardiol 62 2009 875 885
31. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J. 2007;28:2375-414.
32. J. Marrugat, R. D'Agostino, L. Sullivan, R. Elosua, P. Wilson, and J. Ordovas An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas J Epidemiol Community Health 57 2003 634 638
33. D.M. Lloyd-Jones, B.H. Nam, R.B. D'Agostino, D. Levy, J.M. Murabito, and T.J. Wang Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring JAMA 291 2004 2204 2211
34. P.R. Jackson, E.J. Wallis, I.U. Haq, and L.E. Ramsay HMG CoA reductase inhibitors (statins) for primary prevention: at what coronary risk is safety assured? Br J Clin Pharmacol 52 2001 439 446
35. L.E. Chambless, G. Heiss, A.R. Folsom, W. Rosamond, M. Szklo, and A.R. Sharrett Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993 Am J Epidemiol 146 1997 483 494
36. Ankle Brachial Index Collaboration Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis JAMA 300 2008 197 208
37. F.G. Fowkes, L.P. Low, S. Tuta, J. Kozak AGATHA Investigators Ankle-brachial index and extent of atherothrombosis in 8891 patients with or at risk of vascular disease: results of the international AGATHA study Eur Heart J 27 2006 1861 1867
38. R. Ramos, M. Quesada, P. Solanas, I. Subirana, J. Sala, and J. Vila Prevalence of symptomatic and asymptomatic peripheral arterial disease and the value of the ankle-brachial index to stratify cardiovascular risk Eur J Vasc Endovasc Surg 38 2009 305 311
39. M.T. Alzamora, J.M. Baena-Díez, M. Sorribes, R. Forés, P. Toran, M. Vicheto PERART study Peripheral Arterial Disease study (PERART): prevalence and predictive values of asymptomatic peripheral arterial occlusive disease related to cardiovascular morbidity and mortality BMC Public Health 7 2007 348
40. P.W. Wilson Challenges to improve coronary heart disease risk assessment JAMA 302 2009 2369 2370
41. T.J. Wang, P. Gona, M.G. Larson, G.H. Tofler, D. Levy, and C. Newton-Cheh Multiple biomarkers for the prediction of first major cardiovascular events and death N Engl J Med 355 2006 2631 2639
42. J. Danesh, J.G. Wheeler, G.M. Hirschfield, S. Eda, G. Eiriksdottir, and A. Rumley C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease N Engl J Med 350 2004 1387 1397
43. A.C. Morrison, L.A. Bare, L.E. Chambless, S.G. Ellis, M. Malloy, and J.P. Kane Prediction of coronary heart disease risk using a genetic risk score: the Atherosclerosis Risk in Communities Study Am J Epidemiol 166 2007 28 35
44. N.J. Samani, J. Erdmann, A.S. Hall, C. Hengstenberg, M. Mangino, and B. Mayer Genomewide association analysis of coronary artery disease N Engl J Med 357 2007 443 453 (Pubitemid 47204873)
45. S. Kathiresan, O. Melander, C. Guiducci, A. Surti, N.P. Burtt, and M.J. Rieder Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein colesterol or triglycerides in humans Nat Genet 40 2008 189 197
46. D.A. Tregouet, I.R. Konig, J. Erdmann, A. Muteanu, P.S. Braund, and A.S. Hall Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease Nat Genet 41 2009 283 285
47. R. Elosua, C. Lluis, and G. Lucas Estudio del componente genético de la cardiopatía isquémica: de los estudios de ligamiento a la genotipificación integral del genoma Rev Esp Cardiol 9 2009 B24 B38
48. J. Erdmann, A. Grosshennig, P.S. Braund, I.R. König, C. Hengstenberg, and A.S. Hall New susceptibility locus for coronary artery disease on chromosome 3q22.3 Nat Genet 41 2009 280 282
49. Myocardial Infarction Genetics Consortium Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants Nat Genet 41 2009 334 341
50. A. Helgadottir, G. Thorleifsson, A. Manolescu, S. Gretarsdottir, T. Blondal, and A. Jonasdottir A common variant on chromosome 9p21 affects the risk of myocardial infarction Science 316 2007 1491 1493 (Pubitemid 46906618)
51. R. McPherson, A. Pertsemlidis, N. Kavaslar, A. Stewart, R. Roberts, and D.R. Cox A common allele on chromosome 9 associated with coronary heart disease Science 316 2007 1488 1491
52. J. Novembre, T. Johnson, K. Bryc, Z. Kutalik, A.R. Boyko, and A. Auton Genes mirror geography within Europe Nature 456 2008 98 101
53. N.R. Cook, and P.M. Ridker Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures Ann Intern Med 150 2009 795 802
54. A.J. Taylor, C.N. Merz, and J.E. Udelson 34th Bethesda Conference: Executive summary-can atherosclerosis imaging techniques improve the detection of patients at risk for ischemic heart disease? J Am Coll Cardiol 41 2003 1860 1862
55. A.W. Leber, A. Becker, A. Knez, F. Von Ziegler, M. Sirol, and K. Nikolaou Accuracy of 64-slice computed tomography to classify and quantify plaque volumes in the proximal coronary system: a comparative study using intravascular ultrasound J Am Coll Cardiol 47 2006 672 677